Intensive induction chemotherapy vs hypomethylating agent–based regimen in patients aged ≥70 years with newly diagnosed acute myeloid leukemia
暂无分享,去创建一个
A. Raptis | A. Im | K. Dorritie | M. Boyiadzis | R. Redner | Seah H. Lim | Jingzhou Hou | A. Agha | Stanley Marks | A. Sehgal | M. Agha | M. J. Lim